Science Explorer Interactive view Map
Company · London · United Kingdom

Aimmune Therapeutics (United Kingdom)

Research works
56
▼ 26% vs 2013–17
Citations
2.1k
37.6 per fractional work
Top-10% rate
3.6%
record average 16.5%
Open access
43%
world 28%

Not ranked overall: Aimmune Therapeutics (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Aimmune Therapeutics (United Kingdom)?

Ranked on the composite score, Andrea Vereda lead among researchers whose main affiliation is Aimmune Therapeutics (United Kingdom).

  1. 1 Andrea Vereda United Kingdom · #1,461,554 worldwide 9 citations · 19 works
All ranked researchers at Aimmune Therapeutics (United Kingdom)

Which keywords describe research at Aimmune Therapeutics (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Management, Diagnosis, Glycosylation, Children, Inflammation, Prevalence and Monoclonal Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology10▲ 4.6×16 topics
  2. Management7▲ 16×7 topics
  3. Diagnosis7▲ 12×7 topics
  4. Inflammation6▲ 4.7×21 topics
  5. Children5▲ 36×2 topics
  6. Glycosylation5▲ 42×3 topics
  7. Prevalence5▲ 21×2 topics
  8. Cancer Immunotherapy4▲ 56×3 topics
  9. Monoclonal Antibodies4▲ 55×3 topics
  10. Anaphylaxis4▲ 268×1 topic
  11. Food Allergy4▲ 268×1 topic
  12. Cancer4▲ 5.0×10 topics
  13. Immunity4▲ 21×4 topics
  14. Therapeutic Antibodies4▲ 55×2 topics
  15. Antibody Engineering3▲ 61×1 topic
  16. Fc Receptors3▲ 61×1 topic
  17. Asthma3▲ 42×2 topics
  18. Treatment3▲ 4.0×7 topics
  19. Immunotherapy3▲ 7.9×8 topics
  20. Tumor Microenvironment3▲ 13×6 topics
  21. Quality of Life2▲ 3.3×5 topics
  22. Metabolism2▲ 6.5×3 topics
  23. Innate Immunity2▲ 11×6 topics
  24. Tumor Regression2▲ 43×2 topics
  25. TGF-ß2▲ 20×3 topics
  26. Activation2▲ 94×1 topic
  27. Antigen Presentation2▲ 34×2 topics
  28. Lymphoma2▲ 22×3 topics
  29. Macrophage2▲ 58×1 topic
  30. Biopharmaceuticals2▲ 46×3 topics
  31. CAR T Cells2▲ 73×1 topic
  32. Chimeric Antigen Receptor2▲ 73×1 topic
  33. Allergen-specific Immunotherapy2▲ 74×1 topic
  34. Biological Evaluation2▲ 24×2 topics
  35. Dendritic Cells2▲ 27×1 topic
  36. Fibrosis2▲ 16×3 topics
  37. Monoclonal Antibody2▲ 43×2 topics
  38. Pollen Allergy2▲ 74×1 topic
  39. Tumor Antigen2▲ 38×1 topic
  40. Epithelial-Mesenchymal Transition1▲ 29×2 topics

Which research topics does Aimmune Therapeutics (United Kingdom) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Food Allergy and Anaphylaxis Research and Phagocytosis and Immune Regulation.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Food Allergy and Anaphylaxis Research Immunology and Allergy 1 works
  4. 4 Phagocytosis and Immune Regulation Immunology 1 works
  5. 5 Immune Cell Function and Interaction Immunology 1 works
  6. 6 Immunotherapy and Immune Responses Immunology 0 works
  7. 7 Contact Dermatitis and Allergies Dermatology 0 works
  8. 8 Eosinophilic Esophagitis Surgery 0 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
  10. 10 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.4%not open56.6%

World: 28% of research is openly available.

with international co-authors44.1%domestic only55.9%

World: 19% is written across borders.

How has Aimmune Therapeutics (United Kingdom)'s research output changed?

Output in 2018–2022 was 26% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in London

All research institutions in London

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.